Recent Advances in Bioequivalence Testing: Emerging Technologies and AI Tools
Explore how AI, advanced imaging, and new FDA guidelines are transforming bioequivalence testing in 2026, reducing costs and accelerating generic drug approvals.
Explore how AI, advanced imaging, and new FDA guidelines are transforming bioequivalence testing in 2026, reducing costs and accelerating generic drug approvals.
Learn how community health presentations are helping patients understand that generic drugs are just as safe and effective as brand-name ones - and how they save billions each year.
Provider education on generics improves clinician confidence, boosts patient adherence, and cuts costs. Learn how evidence-based training closes knowledge gaps and transforms prescribing habits.
Generic drugs now make up over 90% of U.S. prescriptions, saving $373 billion in 2021 alone. Their rise was driven by landmark laws like the Hatch-Waxman Act, FDA reforms, and cost-saving policies - not luck.
Authorized generics are identical to brand-name drugs in every way except the label. Learn how they differ from regular generics, why they exist, and when to ask for them to avoid side effects or ensure effectiveness.
Therapeutic Equivalence Codes (TE Codes) tell pharmacists which generic drugs are safe to substitute for brand-name versions. Learn how the FDA uses these codes to ensure safety, save money, and expand access to affordable medications.